Commission Decision of 19 April 2010 on the European Databank on Medical Devices (Eudamed) (notified under document C(2010) 2363) (Text with EEA relevance) (2010/227/EU)
Grade B
mapped from publisher markup. A grade says how a document's structure was obtained, not how reliable the law is.
Address https://gelex.eu/eli/EU/decision/2010/227@2010-04-19/en
Contents
- Preamble
- ANNEX
- ANNEX Table detailing the mandatory data fields in the respective module in the Eudamed databank according to the obligations arising from Directives 93/42/EEC, 90/385/EEC and 98/79/EC 1.2.3.4.5.6.7.8.9.10.11.12.
- ANNEX Table detailing the mandatory data fields in the respective module in the Eudamed databank according to the obligations arising from Directives 93/42/EEC, 90/385/EEC and 98/79/EC 1.
- ANNEX Table detailing the mandatory data fields in the respective module in the Eudamed databank according to the obligations arising from Directives 93/42/EEC, 90/385/EEC and 98/79/EC 1.2.
- ANNEX Table detailing the mandatory data fields in the respective module in the Eudamed databank according to the obligations arising from Directives 93/42/EEC, 90/385/EEC and 98/79/EC 1.2.3.
- ANNEX Table detailing the mandatory data fields in the respective module in the Eudamed databank according to the obligations arising from Directives 93/42/EEC, 90/385/EEC and 98/79/EC 1.2.3.4.
- ANNEX Table detailing the mandatory data fields in the respective module in the Eudamed databank according to the obligations arising from Directives 93/42/EEC, 90/385/EEC and 98/79/EC 1.2.3.4.5.
- ANNEX Table detailing the mandatory data fields in the respective module in the Eudamed databank according to the obligations arising from Directives 93/42/EEC, 90/385/EEC and 98/79/EC 1.2.3.4.5.6.7.8.
- ANNEX Table detailing the mandatory data fields in the respective module in the Eudamed databank according to the obligations arising from Directives 93/42/EEC, 90/385/EEC and 98/79/EC 1.2.3.4.5.6.7.8.9.10.
THE EUROPEAN COMMISSION,
Having regard to the Treaty on the Functioning of the European Union,
Having regard to Council Directive 90/385/EEC of 20 June 1990 on the approximation of the laws of the Member States relating to active implantable medical devices, and in particular Article 10b(3) thereof,
Having regard to Council Directive 93/42/EEC of 14 June 1993 concerning medical devices, and in particular Article 14a(3) thereof,
Having regard to Directive 98/79/EC of the European Parliament and of the Council of 27 October 1998 on in vitro diagnostic medical devices, and in particular Article 12(3) thereof,
Whereas:
(1) Directives 90/385/EEC, 93/42/EEC and 98/79/EC contain provisions on a European databank for medical devices which require the establishment of that databank.
(2) The aim of the European databank for medical devices is to strengthen market surveillance by providing competent authorities with fast access to information on manufacturers and authorised representatives, devices and certificates and to vigilance data, to share information on clinical investigation data, as well as to contribute to a uniform application of those Directives, in particular in relation to registration requirements.
(3) The databank should therefore contain the data required by Directives 90/385/EEC, 93/42/EEC and 98/79/EC, in particular on registration of manufacturers and devices, data relating to certificates issued or renewed, modified, supplemented, suspended, withdrawn or refused, data obtained in accordance with the vigilance procedure and data on clinical investigations.
(4) Such a databank has been developed by the European Commission in cooperation with the Member States under the name European Databank for Medical Devices (Eudamed) and is being used by numerous Member States on a voluntary basis.
(5) The data should be entered into the databank using prescribed data transfer methods.
(6) It is appropriate to use an internationally recognised nomenclature for medical devices when entering data into Eudamed in order to allow a uniform description of the devices concerned and efficient use of that databank. Given that data can be entered in all official languages of the Community, a numeric code should be used so that devices can be easily searched.
(7) The Global Medical Device Nomenclature that has been developed based on EN ISO 15225:2000 Nomenclature — Specification for a nomenclature system for medical devices for the purpose of regulatory data exchange is such an internationally recognised nomenclature. The need to establish and maintain Eudamed and to start implementing the Global Medical Device Nomenclature as a basis for that databank was recalled in the Council Conclusions of 2 December 2003 on Medical Devices.
(8) An appropriate transitional period is necessary to allow Member States to prepare for the mandatory use of Eudamed and to take account of the changes introduced by Directive 2007/47/EC of the European Parliament and of the Council of 5 September 2007 amending Council Directive 90/385/EEC on the approximation of the laws of the Member States relating to active implantable medical devices, Council Directive 93/42/EEC concerning medical devices and Directive 98/8/EC concerning the placing of biocidal products on the market.
(9) Member States should only be required to enter data existing before 1 May 2011 to the extent required for the future functioning of Eudamed. It is necessary for the completeness of Eudamed to enter data existing before 1 May 2011 on the manufacturer, the authorised representative and on device registration, which are required by Directives 93/42/EEC and 98/79/EC, in the form in which such data are available at national level.
(10) The measures provided for in this Decision are in accordance with the opinion of the Committee on Medical Devices,
HAS ADOPTED THIS DECISION:
Article 1
This Decision establishes the European Databank on Medical Devices (Eudamed) as databank for the purposes of Article 10b(3) of Directive 90/385/EEC, Article 14a(3) of Directive 93/42/EEC and Article 12(3) of Directive 98/79/EC.
Article 2
Member States shall ensure that the data referred to in points (a) and (b) of Article 10b(1) of Directive 90/385/EEC, points (a), (b) and (c) of Article 14a(1) of Directive 93/42/EEC and points (a), (b) and (c) of Article 12(1) of Directive 98/79/EC, are entered into Eudamed in accordance with the Annex to this Decision. For clinical investigations Member States shall ensure that an extract of the notifications referred to in Article 10(1) of Directive 90/385/EEC and in Article 15(1) of Directive 93/42/EEC, as well as the information referred to in Article 10(3) and (4) of Directive 90/385/EEC and in Article 15(6) and (7) of Directive 93/42/EEC are entered into Eudamed in accordance with the Annex to this Decision.
Article 3
Eudamed shall use the Hypertext Transfer Protocol Secure (HTTPS) and the Extensible Mark-up Language (XML).
Article 4
When entering data in Eudamed, Member States may choose between on-line data entry and up-loading of XML files. Member States shall ensure that when entering data into Eudamed medical devices are described using a code from an internationally recognised nomenclature for medical devices.
Article 5
As concerns data existing before the date referred to in Article 6, Member States shall ensure that the data on registration of manufacturers, authorised representatives and devices are entered into Eudamed in accordance with Article 14a(1)(a) of Directive 93/42/EEC and Article 12(1)(a) of Directive 98/79/EC. That data shall be entered by 30 April 2012 at the latest.
Article 6
Member States shall apply this Decision from 1 May 2011.
Article 7
This Decision is addressed to the Member States.
Done at Brussels, 19 April 2010. For the Commission John Dalli Member of the Commission
ANNEX
ANNEX Table detailing the mandatory data fields in the respective module in the Eudamed databank according to the obligations arising from Directives 93/42/EEC, 90/385/EEC and 98/79/EC 1.2.3.4.5.6.7.8.9.10.11.12.
Directive 93/42/EEC Minimum data required for Eudamed data entry Article 14a(1)(a) and Article 14(1) and (2) Actor (manufacturer/authorised representative): Device: Article 14a(1)(b) Certificate: Article 14a(1)(c) and Article 10(3) Incident (National Competent Authority Report): Article 14a(1)(d) and Article 15(1), (6) and (7) Clinical Investigation: Directive 90/385/EEC Minimum data required for Eudamed data entry Article 10b(1)(a) Certificate (see fields under 3. Certificate) Article 10b(1)(b) and Article 8(3) Incident (see fields under 4. Incident) Article 10b(1)(c) and Article 10(1), (3) and (4) Clinical Investigation (see fields under 5. Clinical Investigation, (a) to (f)): Directive 98/79/EC Minimum data required for Eudamed data entry Article 12(1)(a) and Article 10(1), (3) and (4) and Annex VIII (4) Actor (for all in vitro diagnostic medical devices (IVD’s): Address of manufacturer, respectively authorised representative (see fields under 1. Actor). Device: For all IVD’s In addition for Annex II and self-testing Article 12(1)(b) Certificate (see fields under 3. Certificate) Article 12(1)(c) and Article 11(3) Incident (see fields under 4. Incident)
ANNEX Table detailing the mandatory data fields in the respective module in the Eudamed databank according to the obligations arising from Directives 93/42/EEC, 90/385/EEC and 98/79/EC 1.
(a) Name;
(b) Street;
(c) Locality;
(d) Postcode;
(e) Country;
(f) Phone or E-mail;
(g) Role.
ANNEX Table detailing the mandatory data fields in the respective module in the Eudamed databank according to the obligations arising from Directives 93/42/EEC, 90/385/EEC and 98/79/EC 1.2.
(a) Internationally recognised nomenclature code (for data generated after 1 May 2011);
(b) Device Name/Make or, where not available, generic name.
ANNEX Table detailing the mandatory data fields in the respective module in the Eudamed databank according to the obligations arising from Directives 93/42/EEC, 90/385/EEC and 98/79/EC 1.2.3.
(a) Certificate number;
(b) Certificate type;
(c) Date of Issue;
(d) Expiration Date;
(e) Manufacturer and, if applicable, authorised representative (see fields under 1. Actor);
(f) Notified Body (selected from system);
(g) General Scope description and, where applicable, details on device (see fields under 2. Device);
(h) Status and, where applicable, reasons for decision of Notified Body.
ANNEX Table detailing the mandatory data fields in the respective module in the Eudamed databank according to the obligations arising from Directives 93/42/EEC, 90/385/EEC and 98/79/EC 1.2.3.4.
(a) Competent Authority reference;
(b) Manufacturer, where applicable authorised representative (see fields under 1. Actor);
(c) Manufacturer contact;
(d) Manufacturer reference/Field Safety Corrective Action (FSCA) nr.;
(e) Device (see fields under 2. Device), plus where applicable lot number, serial number, software version;
(f) Notified Body (selected from system);
(g) Device known to be in the market in;
(h) Confidential;
(i) Complete investigation;
(j) Background Information (Description);
(k) Conclusion;
(l) Recommendation;
(m) Action and action description.
ANNEX Table detailing the mandatory data fields in the respective module in the Eudamed databank according to the obligations arising from Directives 93/42/EEC, 90/385/EEC and 98/79/EC 1.2.3.4.5.
(a) Manufacturer, where applicable authorised representative (see fields under 1. Actor);
(b) Device (see fields under 2. Device);
(c) Title of investigation;
(d) Protocol number;
(e) Primary objective;
(f) Competent Authority Contact for this Clinical Investigation;
(g) Decisions taken by Competent Authority pursuant to Article 15(6), date of decision and grounds;
(h) Early termination on safety grounds pursuant to Article 15(7), date of decision and grounds.
ANNEX Table detailing the mandatory data fields in the respective module in the Eudamed databank according to the obligations arising from Directives 93/42/EEC, 90/385/EEC and 98/79/EC 1.2.3.4.5.6.7.8.
(a) Decisions taken by Competent Authority pursuant to Article 10(3), date of decision and grounds;
(b) Early termination on safety grounds pursuant to Article 10(4), date of decision and grounds.
ANNEX Table detailing the mandatory data fields in the respective module in the Eudamed databank according to the obligations arising from Directives 93/42/EEC, 90/385/EEC and 98/79/EC 1.2.3.4.5.6.7.8.9.10.
(a) Device (see fields under Device 2.);
(b) Information on whether device is new;
(c) Discontinuation of placing on the market.
(d) Outcome of performance evaluation, where applicable;
(e) Certificates (see fields under 3. Certificate);
(f) Conformity with Common Technical Specifications, where applicable;
(g) Identification of device.
Versions
Cited by
- Definitive adoption (EU, Euratom) 2024/207 of the European Union’s annual budget for the financial year 2024 Act · Grade B
Total Union contribution 90288652 of which amount coming from the recovery of surplus (revenue Article 6 6 2) 17866467 Amount entered in the budget 72422185 Assigned revenue (origin, estimated amounts and corresponding article or item of the statement of revenue): EFTA-EEA 2592714 6 6 0 0 Regulation (EC) No 851/2004 of the European Parliament and of the Council of 21 April 2004 establishing a European Centre for disease prevention and control (OJ L 142, 30.4.2004, p. 1). Regulation (EU) 2022/2370 of the European Parliament and of the Council of 23 November 2022 amending Regulation (EC) No 851/
- Corrigendum to Regulation (EU) 2017/746 of the European Parliament and of the Council of 5 April 2017 on in vitro diagnostic medical devices and repealing Directive 98/79/EC and Commission Decision 2010/227/EU (Official Journal of the European Union L 117 of 5 May 2017) Corrigendum · Grade B
By way of derogation from Article 10 and points (a) and (b) of Article 12(1) of Directive 98/79/EC, manufacturers, authorised representatives, importers and notified bodies which, during the period starting on the later of the dates referred to in point (f) of Article 113(3) and ending 18 months later, comply with Article 27(3) and Article 28(1) and Article 51(5) of this Regulation shall be considered to comply with the laws and regulations adopted by Member States in accordance with Article 10 and points (a) and (b) of Article 12(1) of Directive 98/79/EC as specified in Decision 2010/227/EU.,
- Corrigendum to Regulation (EU) 2017/746 of the European Parliament and of the Council of 5 April 2017 on in vitro diagnostic medical devices and repealing Directive 98/79/EC and Commission Decision 2010/227/EU (Official Journal of the European Union L 117 of 5 May 2017) Corrigendum · Grade B
By way of derogation from Article 10, points (a) and (b) of Article 12(1) and Article 15(5) of Directive 98/79/EC, manufacturers, authorised representatives, importers and notified bodies which, during the period starting on the later of the dates referred to in point (f) of Article 113(3) and ending 18 months later, comply with Articles 26(3), 28(1) and 51(5) of this Regulation shall be considered to comply with the laws and regulations adopted by Member States in accordance with Article 10, points (a) and (b) of Article 12(1) and Article 15(5) of Directive 98/79/EC as specified in Decision 2
- Regulation (EU) 2024/1689 of the European Parliament and of the Council of 13 June 2024 laying down harmonised rules on artificial intelligence and amending Regulations (EC) No 300/2008, (EU) No 167/2013, (EU) No 168/2013, (EU) 2018/858, (EU) 2018/1139 and (EU) 2019/2144 and Directives 2014/90/EU, (EU) 2016/797 and (EU) 2020/1828 (Artificial Intelligence Act) (Text with EEA relevance) Regulation · Grade B
Directive 2006/42/EC of the European Parliament and of the Council of 17 May 2006 on machinery, and amending Directive 95/16/EC (OJ L 157, 9.6.2006, p. 24); Directive 2009/48/EC of the European Parliament and of the Council of 18 June 2009 on the safety of toys (OJ L 170, 30.6.2009, p. 1); Directive 2013/53/EU of the European Parliament and of the Council of 20 November 2013 on recreational craft and personal watercraft and repealing Directive 94/25/EC (OJ L 354, 28.12.2013, p. 90); Directive 2014/33/EU of the European Parliament and of the Council of 26 February 2014 on the harmonisation of t
- Definitive adoption (EU, Euratom) 2026/72 of the European Union’s annual budget for the financial year 2026 Act · Grade B
Total Union contribution 92034281 of which amount coming from the recovery of surplus (revenue Article 6 6 2) 1094727 Amount entered in the budget 90939554 Assigned revenue (origin, estimated amounts and corresponding article or item of the statement of revenue): EFTA-EEA 2400804 6 6 0 0 Regulation (EC) No 851/2004 of the European Parliament and of the Council of 21 April 2004 establishing a European Centre for disease prevention and control (OJ L 142, 30.4.2004, p. 1, ELI: http://data.europa.eu/eli/reg/2004/851/oj). Regulation (EU) 2022/2370 of the European Parliament and of the Council of 23
- Definitive Adoption (EU, Euratom) 2024/2908 of Amending budget No 4 of the European Union for the financial year 2024 Act · Grade B
Assigned revenue (origin, estimated amounts and corresponding article or item of the statement of revenue). EFTA-EEA 42911479 6 6 0 0 DECENTRALISED AGENCIES Title Chapter Article Item Heading FF 2024 appropriations Amending budget No 4/2024 New amount Commitments Payments Commitments Payments Commitments Payments 04 10DECENTRALISED AGENCIES 04 10 01 European Union Agency for the Space Programme 1 78463345 78463345 308000 308000 78771345 78771345 Chapter 04 10 — Total 78463345 78463345 308000 308000 78771345 78771345 Appropriations under this chapter are intended to cover the decentralised agen
- Definitive adoption (EU, Euratom) 2021/417 of the European Union’s general budget for the financial year 2021 Act · Grade B
This appropriation is also intended to cover the maintenance of the emergency facility (Emergency Operations Centre) linking the ECDC online with national communicable disease centres and reference laboratories in Member States in the event of major outbreaks of communicable diseases or other illnesses of unknown origin. Total Union contribution 79995020 of which amount coming from the recovery of surplus (revenue Article 6 6 2) 1469306 Amount entered in the budget 78525714 Assigned revenue (origin, estimated amounts and corresponding article or item of the statement of revenue): EFTA-EEA 2120
- Commission Implementing Regulation (EU) 2017/2185 of 23 November 2017 on the list of codes and corresponding types of devices for the purpose of specifying the scope of the designation as notified bodies in the field of medical devices under Regulation (EU) 2017/745 of the European Parliament and of the Council and in vitro diagnostic medical devices under Regulation (EU) 2017/746 of the European Parliament and of the Council (Text with EEA relevance) Regulation · Grade B
Having regard to Regulation (EU) 2017/746 of the European Parliament and of the Council of 5 April 2017 on in vitro diagnostic medical devices and repealing Directive 98/79/EC and Commission Decision 2010/227/EU, and in particular Articles 35(10) and 38(13) thereof,
- Commission Implementing Regulation (EU) 2025/2526 of 16 December 2025 amending Implementing Regulation (EU) 2023/2713 to correct the designation of an EU reference laboratory and to designate European Union reference laboratories for in vitro diagnostic medical devices intended for detection or quantification of markers of parasite infection and detection of blood grouping markers (Text with EEA relevance) Regulation · Grade B
Having regard to Regulation (EU) 2017/746 of the European Parliament and of the Council of 5 April 2017 on in vitro diagnostic medical devices and repealing Directive 98/79/EC and Commission Decision 2010/227/EU, and in particular Article 100(1) thereof,
- Definitive adoption (EU, Euratom) 2022/2396 of amending budget No 5 of the European Union for the financial year 2022 Act · Grade B
Title Heading Budget 2022 Amending budget No 5/2022 New amount Commitments Payments Commitments Payments Commitments Payments 01 RESEARCH AND INNOVATION 13236770624 13558016676 13236770624 13558016676 02 EUROPEAN STRATEGIC INVESTMENTS 5506694851 4853018709 1800000 1800000 5508494851 4854818709 Reserves (30 02 02) 2487000 2487000 -1800000 -1800000 687000 687000 5509181851 4855505709 5509181851 4855505709 03 SINGLE MARKET 952519960 903584361 70000000 1022519960 903584361 Reserves (30 02 02) 69000 69000 69000 69000 952588960 903653361 70000000 1022588960 903653361 04 SPACE 2076537905 2156359905 2
- Directive (EU) 2020/1828 of the European Parliament and of the Council of 25 November 2020 on representative actions for the protection of the collective interests of consumers and repealing Directive 2009/22/EC (Text with EEA relevance) Directive · Grade B
Regulation (EU) 2017/746 of the European Parliament and of the Council of 5 April 2017 on in vitro diagnostic medical devices and repealing Directive 98/79/EC and Commission Decision 2010/227/EU (OJ L 117, 5.5.2017, p. 176): Chapter II.
- Commission Implementing Regulation (EU) 2026/977 of 4 May 2026 laying down certain uniform quality management and procedural requirements for the conformity assessment activities carried out by a notified body designated under Regulations (EU) 2017/745 and (EU) 2017/746 of the European Parliament and of the Council (Text with EEA relevance) Regulation · Grade B
Having regard to Regulation (EU) 2017/746 of the European Parliament and of the Council of 5 April 2017 on in vitro diagnostic medical devices and repealing Directive 98/79/EC and Commission Decision 2010/227/EU, and in particular Article 32(3) thereof,
- Commission Implementing Regulation (EU) 2022/944 of 17 June 2022 laying down rules for the application of Regulation (EU) 2017/746 of the European Parliament and of the Council as regards the tasks of and criteria for European Union reference laboratories in the field of in vitro diagnostic medical devices (Text with EEA relevance) Regulation · Grade B
Having regard to Regulation (EU) 2017/746 of the European Parliament and of the Council of 5 April 2017 on in vitro diagnostic medical devices and repealing Directive 98/79/EC and Commission Decision 2010/227/EU, and in particular Article 100(8), point (a), thereof,
- Council Decision (EU) 2026/1535 of 25 June 2026 on the position to be adopted on behalf of the European Union within the Joint Committee established by the Agreement between the European Community and the Principality of Monaco on the application of certain Community acts on the territory of the Principality of Monaco concerning amendments to the Annex to that Agreement Decision · Grade B
MEDICAL DEVICES Council Directive 90/385/EEC of 20 June 1990 on the approximation of the laws of the Member States relating to active implantable medical devices (OJ L 189, 20.7.1990, p. 17). Council Directive 93/42/EEC of 14 June 1993 concerning medical devices (OJ L 169, 12.7.1993, p. 1). Directive 98/79/EC of the European Parliament and of the Council of 27 October 1998 on in vitro diagnostic medical devices (OJ L 331, 7.12.1998, p. 1). Commission Decision 2002/364/EC of 7 May 2002 on common technical specifications for in vitro-diagnostic medical devices (OJ L 131, 16.5.2002, p. 17), as am
- Commission Delegated Regulation (EU) 2023/503 of 1 December 2022 amending Regulation (EU) 2017/746 of the European Parliament and of the Council as regards the frequency of complete re-assessments of notified bodies (Text with EEA relevance) Regulation · Grade B
Having regard to Regulation (EU) 2017/746 of the European Parliament and of the Council of 5 April 2017 on in vitro diagnostic medical devices and repealing Directive 98/79/EC and Commission Decision 2010/227/EU, and in particular Article 40(11) thereof,
- Council Decision of 9 July 2013 on the position to be adopted, on behalf of the European Union, in the Joint Committee established by the Agreement between the European Community and the Principality of Monaco on the application of certain Community acts on the territory of the Principality of Monaco (2013/455/EU) Decision · Grade B
Council Directive 90/385/EEC of 20 June 1990 on the approximation of the laws of the Member States relating to active implantable medical devices (OJ L 189, 20.7.1990, p. 17), as amended by: Council Directive 93/42/EEC of 14 June 1993 concerning medical devices (OJ L 169, 12.7.1993, p. 1), as amended by: Directive 98/79/EC of the European Parliament and of the Council of 27 October 1998 on in vitro diagnostic medical devices (OJ L 331, 7.12.1998, p. 1), as amended by: Commission Decision 2002/364/EC of 7 May 2002 on common technical specifications for in vitro diagnostic medical devices (OJ L
- Commission Implementing Regulation (EU) 2023/2713 of 5 December 2023 designating European Union reference laboratories in the field of in vitro diagnostic medical devices (Text with EEA relevance) Regulation · Grade B
Having regard to Regulation (EU) 2017/746 of the European Parliament and of the Council of 5 April 2017 on in vitro diagnostic medical devices and repealing Directive 98/79/EC and Commission Decision 2010/227/EU, and in particular Article 100(1) thereof,
- Definitive adoption (EU, Euratom) 2021/2221 of Amending budget No 6 of the European Union for the financial year 2021 Act · Grade B
This appropriation is also intended to cover the maintenance of the emergency facility (Emergency Operations Centre) linking the ECDC online with national communicable disease centres and reference laboratories in Member States in the event of major outbreaks of communicable diseases or other illnesses of unknown origin. Total Union contribution 119995020 of which amount coming from the recovery of surplus (revenue Article 6 6 2) 1469306 Amount entered in the budget 118525714 Assigned revenue (origin, estimated amounts and corresponding article or item of the statement of revenue): EFTA-EEA 21
- Regulation (EU) 2017/746 of the European Parliament and of the Council of 5 April 2017 on in vitro diagnostic medical devices and repealing Directive 98/79/EC and Commission Decision 2010/227/EU (Text with EEA relevance) Regulation · Grade B
One key aspect in fulfilling the objectives of this Regulation is the creation of a European database on medical devices (Eudamed) that should integrate different electronic systems to collate and process information regarding devices on the market and the relevant economic operators, certain aspects of conformity assessment, notified bodies, certificates, performance studies, vigilance and market surveillance. The objectives of the database are to enhance overall transparency, including through better access to information for the public and healthcare professionals, to avoid multiple reporti
- Regulation (EU) 2017/746 of the European Parliament and of the Council of 5 April 2017 on in vitro diagnostic medical devices and repealing Directive 98/79/EC and Commission Decision 2010/227/EU (Text with EEA relevance) Regulation · Grade B
Directive 98/79/EC should be repealed to ensure that only one set of rules applies to the placing of in vitro diagnostic medical devices on the market and the related aspects covered by this Regulation. Manufacturers' obligations as regards the making available of documentation regarding devices they placed on the market and manufacturers' and Member States' obligations as regards vigilance activities for devices placed on the market pursuant to that Directive should however continue to apply. While it should be left to Member States to decide how to organise vigilance activities, it is desira